Effects of vitamin D3 on human lung fibroblasts derived from patients with IPF - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Effects of vitamin D3 on human lung fibroblasts derived from patients with IPF

Résumé

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. Currently, no treatment can stop the progression of IPF. Vitamin D3 (VD) reduces experimental in murine models prevents <i>in vitro</i> activation fibroblasts. Moreover, depletion VD may be associated with reduced survival patients In this context, we determined present study if prevent pro-fibrotic functions human fibroblasts (HLFs) isolated from IPF control HLFs were derived surgical biopsies collected or primary cancer, respectively. (10-100 nM) barely prevented TGF-β1-induced differentiation HLFs. At 100 nM, slightly expression marker α-smooth muscle actin had effect on fibronectin collagen-1 expression. contrast, nM strongly inhibited aerobic glycolytic metabolism induced by TGF-β1 (3-100 also potently basal PDGF-dependent proliferation Using gene silencing technology, demonstrated that such effects mediated vitamin D receptor. addition, altered cell cycle increasing percentage arrested G0/G1 phase downregulating various regulatory proteins. conclusion, our shows low concentrations These results suggest it might interesting to assess potential clinical benefits supplementation IPF, especially slowing function decline.
Fichier non déposé

Dates et versions

hal-04286365 , version 1 (15-11-2023)

Identifiants

Citer

Tom Voisin, Audrey Joannes, Claudie Morzadec, Dominique Lagadic-Gossmann, Cécile Le Naoures Mear, et al.. Effects of vitamin D3 on human lung fibroblasts derived from patients with IPF. ERS International Congress 2023 abstracts, Sep 2023, Milano, Italy. pp.PA559, ⟨10.1183/13993003.congress-2023.pa559⟩. ⟨hal-04286365⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More